Boeing, Capital One Financial, Pfizer: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading. Stock symbols are in parentheses, and prices are as of 5:44 p.m. in New York.

Boeing Co. (BA) : The Chicago-based company is replacing its commercial-jet sales chief, Marlin Dailey, a month after Airbus SAS made inroads into one of the U.S. planemaker’s top customers. Ray Conner, who had been head of sales before Dailey was appointed in December 2008, will take an expanded role as vice president of sales and customer support. Dailey previously led European sales and will become president of Boeing Germany, Northern Europe/EU and Africa.

Capital One Financial Corp. (COF) : The Federal Reserve said it will hold public hearings on the McLean, Virginia-based lender’s acquisition of ING Direct USA. The Fed said the scrutiny is to examine whether the acquisition creates benefits to the public and risks to the stability of the U.S. banking or financial system.

Pfizer Inc. (PFE) added 0.8 percent to $18.35. The world’s largest drugmaker won U.S. approval to sell a drug to treat lung cancer. The treatment, crizotinib, is the leading candidate among more than 20 tumor-fighting medicines the company is developing to help replace sales expected to be lost to generic drugs.

To contact the reporter on this story: Rita Nazareth in New York at rnazareth@bloomberg.net

To contact the editor responsible for this story: Nick Baker at nbaker7@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.